A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients

被引：0
|
作者：
Rajiv Kumar
Shir Kiong Lu
Anna Minchom
Adam Sharp
Michael Davidson
Ranga Gunapala
Timothy A. Yap
Jaishree Bhosle
Sanjay Popat
Mary E. R. O’Brien
机构：
[1] The Royal Marsden NHS Foundation Trust,Department of Medicine
[2] The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 77卷
关键词：
Non-small cell lung cancer; Adenocarcinoma; Capecitabine; Erlotinib; Phase 1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 383
页数：8
相关论文
共 50 条
  • [31] A PHASE I / II TRIAL OF THE HDAC INHIBITOR BELINOSTAT IN COMBINATION WITH ERLOTINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER.
    Andersen, Jon L.
    Holm, Bente
    Rasmussen, Trine S.
    Mellemgaard, Anders
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1201 - S1202
  • [32] A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer
    Gandara, David R.
    Leighl, Natasha
    Delord, Jean-Pierre
    Barlesi, Fabrice
    Bennouna, Jaafar
    Zalcman, Gerald
    Infante, Jeffrey R.
    Reckamp, Karen L.
    Kelly, Karen
    Shepherd, Frances A.
    Mazieres, Julien
    Janku, Filip
    Gardner, Olivia S.
    Mookerjee, Bijoyesh
    Wu, Yuehui
    Cox, Donna S.
    Schramek, Dan
    Peddareddigari, Vijay
    Liu, Yuan
    D'Amelio, Anthony M., Jr.
    Blumenschein, George, Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 556 - 566
  • [33] Randomized phase II trial of radiotherapy with or without erlotinib in patients with locally advanced or unresectable non-small cell lung cancer
    Martinez, E.
    Martinez, M. T.
    de la Torre, A.
    Valcarcel, F.
    Perez, A.
    Domine, M.
    Amador, M. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S510 - S510
  • [34] Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
    Nole, Franco
    Crivellari, D.
    Mattioli, R.
    Pinotti, G.
    Foa, P.
    Verri, E.
    Fougeray, R.
    Brandely, M.
    Goldhirsch, A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 673 - 680
  • [35] Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients
    Xiong, Liwen
    Lou, Yuqing
    Bai, Hao
    Li, Rong
    Xia, Jinjing
    Fang, Wentao
    Zhang, Jie
    Han-Zhang, Han
    Lizaso, Analyn
    Li, Bing
    Gu, Aiqin
    Han, Baohui
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019,
  • [36] Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Thongprasert, Sumitra
    Govindan, Ramaswamy
    Krzakowski, Maciej
    Szczesna, Aleksandra
    Strausz, Janos
    Makhson, Anatoly
    Tye, Lesley
    Zhang, Ke
    Chao, Richard C.
    Scagliotti, Giorgio V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
  • [37] Combination of quinacrine and erlotinib overcomes resistance to erlotinib in non-small cell lung cancer
    Dermavvan, Josephine Kam Tai
    Gurova, Katerina
    Pink, John
    Dowlati, Afshin
    De, Sarmishtha
    Naria, Goutham
    Sharma, Neelesh
    Stark, George
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [38] Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
    Franco Nolè
    D. Crivellari
    R. Mattioli
    G. Pinotti
    P. Foa
    E. Verri
    R. Fougeray
    M. Brandely
    A. Goldhirsch
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 673 - 680
  • [39] Phase 1b study of crizotinib in combination with pembrolizumab in patients (pts) with untreated ALK-positive (+) advanced non-small cell lung cancer (NSCLC)
    Vizcarrondo, F. R.
    Patel, S. P.
    Pennell, N. A.
    Pakkala, S.
    West, H.
    Kratzke, R.
    Tarazi, J.
    Wilner, K.
    Polli, A.
    Tan, W.
    Liu, Y.
    Valota, O.
    Piperdi, B.
    Reckamp, K. L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [40] Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules
    Sutiman, Natalia
    Zhang, Zhenxian
    Tan, Eng Huat
    Ang, Mei Kim
    Tan, Shao-Weng Daniel
    Toh, Chee Keong
    Ng, Quan Sing
    Chowbay, Balram
    Lim, Wan-Teck
    PLOS ONE, 2016, 11 (05):
12345